Gilead Sciences Inc. announced that Kevin Young CBE, Executive Vice President, Commercial Operations, has informed the company of his decision to retire, effective February 04, 2014. Mr. Young will continue to work directly with Gilead's management team as a senior advisor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.61 USD | -1.58% |
|
+10.23% | -14.07% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.07% | 86.72B | |
+55.19% | 815B | |
+45.57% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+19.49% | 247B | |
+3.72% | 229B | |
+14.02% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences, Inc. Announces Retirement of Kevin Young CBE as Executive Vice President, Commercial Operations, Effective February 04, 2014